A Study of BCD-135 in Patients With Advanced Solid Tumors
Status:
Unknown status
Trial end date:
2018-10-31
Target enrollment:
Participant gender:
Summary
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Safety,
and Immunogenicity of BCD-135 (JSC BIOCAD, Russia) in Patients with Advanced Solid Tumors